Vaccine & Gene Therapy Institute of Florida Company Information
Overview
Vaccine & Gene Therapy Institute of Florida is located in FL. Vaccine & Gene Therapy Institute of Florida mainly operate in the Commercial Physical Research industry. Currently they have estimated 51–200 employees.
Website:
-
http://vgtifl.org
Size:
-
51–200 employees
Headquarters:
- 9801 SW Discovery Way, FL 34987
Phone Number:
Industry:
-
Commercial Physical Research
Founded:
-
2008
Employees at Vaccine & Gene Therapy Institute of Florida
Showing 10 of 20| JOB TITLE | WORK EMAIL | WORK PHONE | LOCATION | |
|---|---|---|---|---|
| Executive Administrative Assistant To Dr. Richard Jove, Ceo, President and Director | Hobe Sound, Florida | |||
| Executive Director | Portland, Oregon | |||
| Senior Staff Scientist | Port Saint Lucie, Florida | |||
| Director Of Genomics and Collaborative Genomics Center | Akron, Ohio | |||
| Purchasing Manager | ||||
| Research Assistant | Pierce, Florida | |||
| Manager Scientific Affairs | Tampa, Florida | |||
| Employee | Pierce, Florida | |||
| Senior Research Assistant | Port Saint Lucie, Florida | |||
| Purchasing Manager | Alabama |
Executive Administrative Assistant To Dr. Richard Jove, Ceo, President and Director
Hobe Sound, Florida 
Executive Director
Portland, Oregon
Senior Staff Scientist
Port Saint Lucie, Florida
Director Of Genomics and Collaborative Genomics Center
Akron, Ohio
Purchasing Manager
Research Assistant
Pierce, Florida
Manager Scientific Affairs
Tampa, Florida
Employee
Pierce, Florida
Senior Research Assistant
Port Saint Lucie, Florida
Purchasing Manager
Alabama
Enter an employee name to search and verify work emails, phone numbers and social links etc.
Vaccine & Gene Therapy Institute of Florida's Email Format
We found 3 email formats used by Vaccine & Gene Therapy Institute of Florida employees. The most common Vaccine & Gene Therapy Institute of Florida email format is first_initial last ex.(jdoe@vgtifl.org) being used 95% of the time.
first_initial last
95%
first.last
3%
first_initial.last
3%
